ArticleCureus2025
A Challenging Diagnostic Process: A Case of Lewy Body Dementia in Long-Standing Schizophrenia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lewy body dementia (LBD) is a progressive neurodegenerative disorder presenting with a wide range of cognitive, sleep, neuropsychiatric, motor, and autonomic symptoms. Diagnosing LBD in individuals with established psychiatric conditions, particularly chronic schizophrenia, presents significant challenges due to overlapping clinical features. This case report outlines a case of a 78-year-old woman with a 48-year history of paranoid schizophrenia, who on her last admission exhibited new behavioural and functional decline. This included increased agitation, incoherent mumbling, visual hallucinations, self-harming behaviour, motor symptoms, and reduced responsiveness. Over time, she became increasingly frail and was displaying signs of extrapyramidal side effects on therapeutic doses of haloperidol. Her presentation triggered regular comprehensive multidisciplinary team (MDT) discussions and reassessments, especially when the medical staff noted worsening motor symptoms, hypersensitivity to antipsychotics, and cognitive fluctuations. Although her primary psychiatric diagnosis had been schizophrenia for nearly five decades, the clinical evolution strongly indicated LBD, an emerging neurodegenerative process. Despite the absence of radiologic evidence, largely due to her condition, her new symptoms aligned with the diagnostic criteria for LBD. Subsequently, due to her poor physiological reserve, she was managed under a palliative care pathway. This case highlights the importance of periodic diagnostic reassessment in a patient with a long-standing psychiatric disorder. Without careful review, there is a risk of diagnostic overshadowing, where new symptoms observed are miscredited to a historical diagnosis. Additionally, anchoring bias can further add to the issue as clinicians become fixated on the initial diagnosis. As a result, differentiating between chronic psychosis and evolving neurodegenerative conditions like LBD is crucial to avoid inaccurate management and to develop appropriate care plans, especially in vulnerable patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.